Abel Hall LLC’s Agilon Health AGL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-2,264
Closed -$243K – 896
2026
Q2
$243K Buy
+2,264
New +$148K 0.04% 610
2026
Q1
– Sell
-677
Closed -$11.7K – 818
2025
Q4
$11.7K Buy
+677
New +$13.1K ﹤0.01% 711

Other funds holding AGL

Abel Hall LLC's AGL Position: Q3 2026 in Review

Abel Hall LLC sold out of Agilon Health (AGL) in Q3 2026, closing a stake of 2,264 shares — an estimated $243K sold.

Abel Hall LLC first reported a position in AGL in Q4 2025 and held it in 2 quarters. The position peaked at $243K in Q2 2026. 28 funds tracked by Wall St. Rank hold AGL as of Q3 2026.

  • Abel Hall LLC reported no remaining Agilon Health position as of Q3 2026 after selling out during the quarter.
  • Abel Hall LLC sold 2,264 Agilon Health shares in Q3 2026, an estimated $243K.
  • Abel Hall LLC first reported a position in Agilon Health in Q4 2025 and held it in 2 quarters.
  • Abel Hall LLC's Agilon Health position peaked at $243K in Q2 2026.
  • 28 funds tracked by Wall St. Rank held Agilon Health as of Q3 2026.

Based on Abel Hall LLC's 13F filing for Q3 2026, filed 19 Oct 2026.